Expressing and functional analysis of mammalian apoptotic regulators in yeast by Greenwood, M. T. & Ludovico, Paula
Review
Expressing and functional analysis of mammalian
apoptotic regulators in yeast
MT Greenwood*,1 and P Ludovico*,2
The ease by which yeast can be manipulated in conjunction with their similarities to cells of more complex metazoans makes
many yeast species, particularly Saccharomyces cerevisae, very attractive models for the study of conserved evolutionary
processes that occur in eukaryotes. The ability to functionally express heterologous genes in these cells has allowed the
development of countless new and elegant approaches leading to detailed structure–function analysis of numerous mammalian
genes. Of these, the most informative have been the studies involving the analysis of regulators that have no direct or obvious
sequence orthologue in yeast, including members of the Bcl-2 family of proteins, caspases and tumour suppressors. Here we
review the field and provide evidence that these studies have served to further understand mammalian apoptosis.
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Yeast As a Model to Study Mammalian Apoptotic
Regulators
Apoptosis, the best recognized form of programmed cell
death, is a physiological mechanism that, when inappropri-
ately controlled, causes several diseases.1 Apoptosis is
characterized by an orderly pattern of events under regulation
of a large diversity of key molecular mediators, such as
caspases and the Bcl-2 family members. The large variety of
apoptotic regulators, their numerous interactions and their
dependency on the cell’s genetic makeup and stimuli
complicate the analysis of their individual interactions and
functions within apoptosis. In the 1990s, yeast cells appeared
as an appealing eukaryotic unicellular model system to study
mammalian apoptosis-regulator proteins on the basis of their
powerful genetic tools.2 The exploitation of yeast as a ‘clean
room’ system to study interactions between heterologously
expressed regulatory components of apoptotic pathways has
yielded new insights into apoptosis as will be discussed later.
Nowadays, several studies have shown that yeast cells
possess an ancestral endogenous programmed cell death
machinery. In effect, although Bcl-2 family members, cas-
pases or p53, seem to be absent from yeast genome, some
apoptotic regulators, such as cytochrome c (Cyt c), apoptosis
inducing factor (Aif), HtrA/OMI and endonuclease G have
been implicated in yeast cell death, supporting the hypothesis
that mitochondrial precursors have evolved to possess a
battery of molecules capable of killing host cells.3 In addition,
yeast cells have a metacaspase, a caspase-like protein,4
which shares structural and mechanistic features with
metazoan caspases5 and has been implicated in the majority
of yeast apoptotic scenarios described so far.6 In this context,
heterologous expression of mammalian killers in yeast is even
more exciting as it can serve to uncover new genes or
unknown interactions between common apoptotic regulators/
pathways and drugs that modulate the cell death pathways
of higher eukaryotes. In this review, we examine and revisit
the pioneering studies on the heterologous expression and
functional analysis of Bcl-2 family members, caspases and
tumour suppressors genes in yeast cells.
Analysis of Heterologous Bax Expression in Yeast
Bax-induced cell death in yeast. Mammalian mitochondria-
centered apoptosis is thought to be largely regulated by the Bcl-
2 family of proteins.7 These proteins are identified by the
presence of one or more common Bcl-2 homology (BH)
domains. The approximately 30 Bcl-2 family members can be
classified on the basis of their different functions, as well as the
corresponding BH domains they contain in anti-apoptotic
proteins (e.g. Bcl-2, Bcl-xL and Mcl-1) and pro-apoptotic
proteins (e.g. Bax and Bak). A number of other Bcl-2
members contain a single BH3 domain (so-called BH3-only
proteins, e.g. Bad, Bid, Noxa and Puma) and are largely pro-
apoptotic by virtue of their ability to serve as modulators of the
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other Bcl-2 proteins.7–8 When subjected to appropriate pro-
apoptotic stimuli, there is a concerted interaction of the subset
of Bcl-2 proteins that are present or produced in an individual
cell. As a result, there is a decrease in the function of the anti-
apoptotic Bcl-2 proteins and a concomitant increase in the
activity of the pro-apoptotic Bcl-2 proteins that when activated
are inserted in the mitochondrial outer membrane (MOM),
eliciting a number of mitochondrial functional alterations, such
as the release of apoptosis-promoting factors including Cyt c,8
ultimately leading to the cell’s demise.
The use of human and mouse cell lines that have one or
more deleted Bcl-2-encoding genes, as well as the use of
other tools to decrease the repertoire of functional Bcl-2
proteins, such as drug inhibitors, dominant-negative peptides
and specific siRNAs, facilitates the study of Bcl-2 protein
interactions.9–10 An alternative approach to the study of Bcl-2
proteins is to use a model system such as yeast.11–12
Although yeast does not seem to contain Bcl-2 proteins, it
was nevertheless demonstrated by several groups that
expression of activated Bax leads to cell death. In 1994, Sato
et al.13 used a yeast two-hybrid system to examine Bax–Bcl-2
interactions and accidentally found that Bax confers a lethal
phenotype when expressed in Saccharomyces cerevisiae.
Importantly, Bax lethality can be overcome by co-expressing
the anti-apoptotic proteins: Bcl-2 or Bcl-xL. Subsequently,
Bax expression was also shown to induce cell death in a
variety of different yeast species, such as Schizosaccharo-
myces pombe, Pichia pastoris, Kluyveromyces lactis and
Candida albicans.14–19 S. cerevisiae Bax-induced cell death
was described as resembling autophagy with dismantling of
organelles and cytoplasmatic vacuolization, and thus it was
suggested that these toxic effects were mainly due to the
intrinsic toxicity of the Bax protein, probably mediated by its
ability to promote channel-pore formation.2 Later, Ligr et al.20
showed that a series of morphological changes in yeast cells
expressing human Bax are similar to those observed in
apoptotic metazoan cells namely chromatin condensation,
DNA fragmentation, exposition of phosphatidylserine, plasma
blebbing and reactive oxygen species (ROS) production.
Typical apoptotic features, such as chromatin condensation,
have also been reported after Bax expression in P. pastoris19
and S. pombe.16 Similarly to mammalian cells, Bax expressed
in yeast cells was shown to localize to mitochondria21 and to
induce several mitochondrial dysfunctions,22 such as
changes in mitochondrial membrane potential21 and release
of Cyt c.22 In accordance, Bax killing efficiency is enhanced
under respiratory conditions as compared with fermentative
conditions.21
Analogous to studies performed in mammalian cells,
anti-apoptotic members of the Bcl-2 family, including Bcl-2,
Bcl-xL and Mcl-1, suppress the lethal function of Bax in yeast,
whereas the pro-apoptotic protein, Bcl-xs, and various
deletion mutants of Bcl-2 that are non-functional in mamma-
lian cells do not.13–14,23 Interestingly, even some mutants of
Bcl-2, which retain the ability to bind Bax but which are
deficient in anti-apoptotic activity in mammalian cells are
similarly unable to suppress Bax-mediated lethality in budding
yeast,23 implying that the mere binding of anti-apoptotic Bcl-2
family proteins to Bax is insufficient to abrogate its deadly
function in yeast. These parallels between the effects of wild-
type and mutant Bcl-2 family proteins on yeast cell death
suggest that some aspects of the function of these proteins
may be translatable into less complex organisms and
constitute a strong piece of evidence favoring that
Bax-induced cell death is not the result of a nonspecific
cytotoxicity. Nevertheless, the specificity of Bax function in
yeast cells is still questioned. For example, the expression in
yeast of both mammalian Bcl-2 and the Caenorhabditis
elegans orthologue CED-9 inhibited oxidative stress-
mediated cell death,24 and Bcl-2 was able to alleviate the
oxidant hypersensitivity of yeast cells lacking the gene
encoding superoxide dismutase 2 (Dsod2),25 reflecting a
protective function independent of Bax. The observed
Bax-independent effects are not likely to be artifactual, as
some anti-apoptotic members of the Bcl-2 family were
previously reported to have an antioxidant function in
mammalian cells.26 Studies in the strictly aerobic yeast
K. lactis showed that co-expression of Bcl-xL prevented
Bax toxicity but did not prevent the production of ROS,
suggesting that, at least in K. lactis cells, ROS are not crucial
mediators of Bax-induced cell death and that the anti-
apoptotic function of Bcl-xL is not limited to its antioxidant
property.17 Levine et al.27 also described that a vesicle-
associated membrane protein of Arabidopsis thaliana
suppresses Bax-induced cell death in yeast downstream of
oxidative burst, suggesting that Bax-induced cell death in
yeast might occur, at least in part, by modulating the levels of
ROS24 (Figure 1).
Considerable debate still exists regarding the cellular
components in yeast, which are necessary for Bax-specific
toxicity. Bax cytotoxicity was shown to be independent of the
yeast metacaspase, YCA1. However, it should be noted that
Bax-mediated apoptosis using both caspase-dependent
and caspase-independent processes has been observed in
mammalian systems.28 In addition, one cannot exclude a
putative role of other yeast proteases that might also have a
function in Bax-induced cell death, such as the proteasome,29
the mitochondrial AAA-type protease Yme1p, which is
activated upon Cyt c release,30–31 and vacuolar proteases.
Other mechanisms may also exist, for example, several
pieces of evidence support the involvement of an autophagic
process in Bax-induced cell death in yeast (Figure 1). In effect,
initial visualizations of yeast cells expressing Bax indicated an
extensive cytoplasmic vacuolization.2,20 Later on, it was
shown that a strain defective in central vacuole formation
and membrane trafficking, due to a mutation in ARL1 gene,
was resistant to cell death induced by Bax. These cells do not
present the typical ultrastructural autophagic hallmarks similar
to wild-type cells upon Bax expression, suggesting that Bax-
induced cell death requires efficient membrane trafficking and
vacuole formation.32 Further clues towards identifying the
mechanisms involved are provided by the function of genes
corresponding to mutants identified in genetic screens for
Bax-resistant cells. All the available evidences suggest that
the protein encoded by one such gene Uth1p, participates in
an autophagic pathway involving mitochondria, which is
reminiscent of the requirements for Bax-induced cell death
in yeast33 (Figure 1). Thus, phenotypes of cells lacking UTH1
gene also support the observations that resistance to Bax is
conferred by defects in autophagic and membrane-trafficking
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processes. Eight out of the twelve Bax-resistant strains
identified in another screen displayed defects in the nutrient-
recycling processes associated with autophagy.34 Although
these later results, combined with the observations of mutants
lacking UTH1, provide an interesting link between the
vacuolar and mitochondrial effects of Bax, there are other
scenarios in which mitochondria and the vacuole seem to act
independently and without obvious correlations to each
other.34–35 In effect, Belhocine et al.34 used a mutant strain
highly resistant to Bax to screen for genes which over-
expression could restore Bax sensitivity. These suppressors
promoted Bax sensitivity in a vacuole-dependent but mito-
chondria-independent manner.34 Conversely, another study
found that a Bax-inhibiting glutathione S-transferase protein,
isolated as a high-copy suppressor from a tomato cDNA
library,36 confers protection to Bax cytotoxicity by replacing
the normal mitochondrial, but not the vacuolar, functional
parameters.35–36
Altogether, the data obtained from the study of Bax-induced
cell death in yeast favor the hypothesis that Bax triggers
distinct cell death pathways (Figure 1), in a similar manner as
in mammalian cells. One pathway is dependent on the
autophagic process and another one requires mitochondria.
Interestingly, the Bax-protective effects of the anti-apoptotic
Bcl-2 protein might be related both with its antioxidant,26 as
well as with its anti-autophagic effects37 observed both in
yeast and in mammalian cells. Thus, using yeast-based
systems to reconstitute Bax-induced cell death and its
abrogation by natural adapters might provide, in the near
future, further insights into the function of Bcl-2 family proteins
in mammalian cells.
The study of Bax function in yeast. A number of models
exist to explain how the structurally complex, largely cytosolic
and inactive Bax protein found in healthy cells becomes
activated.7 The early and now largely disputed rheostat
model suggested that Bax was bound to Bcl-2 and alterations
in the levels of either one led to pro- or anti-apoptotic
responses. More recent models take into account the
observed effects of the BH3-only proteins. Although there
is a general picture regarding the function of individual Bcl-2
members, controversies still exist and a large number of
questions remain to be answered.7 Understanding the nature
of the functional interactions between the individual Bcl-2
Figure 1 Schematic representation of the effects of heterologously expressed Bax suppressors in yeast
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members that lead to the apoptotic responses is made more
complicated by the large number of different Bcl-2 members
that are expressed in a given cell. As referred above,
although yeast does not have endogenous Bcl-2 proteins, it
has proven to be a useful in vivo heterologous model for
the functional analysis of the interaction between individual
Bcl-2 proteins, as these proteins retain their function when
expressed in yeast.11–12 For example, early on, the
expression of Bcl-xL mutants unable to bind Bax was
shown to nevertheless retain the ability to prevent some of
the lethal effects of Bax in yeast.38 This was indicative that
some of the effects of Bcl-2 proteins did not require
heterodimerization with other Bcl-2 proteins. Conversely,
early studies on the analysis of Bax mutants in yeast
suggested that Bax homodimerization was important for its
function.39 In effect, the analysis of mutant forms of different
Bcl-2 proteins in yeast was important in delineating many
aspects of the structural function of Bax including the
delineation of the BH domains, as well as other functional
regions such as those involved in mitochondrial targeting.
Yeast continues to be a useful model to study the function of
BH3 proteins. For example, yeast was used in a recent study
to address the controversial issue of whether the BH3-only
protein, Puma, acts as either an activator or a sensitizer in
the process of Bax activation.40 The study made use of the
fact that full-length unaltered Bax (no tag or mutation) when
overexpressed in yeast, will not lead to cell death as Bax is
not activated. The study clearly demonstrated that co-
expression of Puma with inactive Bax leads to increased
Cyt c release and cell death. A variety of controls such as the
fact that Bcl-xL inhibits the lethal effects of the co-expression
of Puma and Bax, and that Puma does not enhance the
killing effect of the active and lethal BaxD33A mutant, point to
the specificity of the observed effects. Thus, Puma is a direct
activator of Bax in a process that does not require other
Bcl-2 proteins including anti-apoptotic Bcl-2 proteins. It is of
interest that full-length unaltered Bax is not lethal in yeast. As
in mammalian cells, Bax must be altered or activated in some
way for it to be competent to induce cell death.8 In
mammalian cells, a number of Bcl-2 proteins have been
implicated in mediating this activation.7 The exact processes
as well as the entire repertoire of events that control and
are necessary for Bax activation is still being actively
investigated.7–8 In yeast, genetic alterations of Bax, such
as fusing it to other proteins, including LexA or a c-myc
epitote, or the introduction of point mutations, such as
BaxD33A, seem necessary for its ability to induce
apoptosis.13–14,21,40 This suggests that yeast cells lack the
ability to activate Bax although a systematic evaluation of this
concept is yet to be undertaken. Nevertheless, genetic
mechanisms may represent common ways to activate Bax.
For example, the alternatively spliced variant, Baxb, is
constitutively active and it may also be able to activate the
inactive Baxa variant.41 Alternatively, a dominant-negative
type splice variant, Bax-w, has also been reported.42 Other
aspects of Bax function studied in yeast are diverse and
include the use of yeast mutants defective in cardiolipin
synthesis to determine the importance of this lipid in Bax
mitochondrial interaction.43 Studies using yeast mutants
defective in different genes encoding mitochondrial proteins
served to identify the translocase of outer mitochondrial
membrane (TOM) complex as being required for the ability of
Bax to mediate the release of Cyt c in yeast.44 Nevertheless,
as with much of the Bax research in other cells, there remain
controversies with some of the results obtained in yeast.11
For example, there are studies suggesting that TOM is not
required for Bax mitochondrial interaction in yeast.45 This is
not surprising given that the issue of the importance of
cardiolipin, TOM as well as other potential Bax receptors on
the mitochondria still remains contentious.46
Finally, the human autophagy regulator Bcl-2-interacting
protein encoded by Beclin 1 contains a functional Bcl-2 BH3
domain. This gene is of further interest as an apoptotic
regulator because it is also a haploid insufficient tumour
suppressor. The human Beclin 1 cDNA can complement the
starvation-induced autophagic defect in yeast strains lacking
the yeast Beclin 1 orthologue called Atg6p.37 In addition,
expression of human or viral Bcl-2 was shown to inhibit
Beclin 1 function in spite of the fact that Bcl-2 does not seem to
interact with yeast Atg6p. Pattingre et al.37 were able to use
this heterologous system to demonstrate that amino-acid
substitutions within Bcl-2 or Beclin 1, which abolished their
interaction also prevented Bcl-2-mediated inhibition of
Beclin 1. Thus in addition to serving as a homologous system
to study endogenous apoptotic processes,47,48 yeast also
serves as an excellent heterologous model system to address
specific aspects of mechanisms of apoptosis that are
unique to the corresponding process present in mammalian
cells.49–50
Genetic screens in yeast cells expressing Bax. In
addition to the direct study of Bax function, numerous
studies using genetic approaches have also proven to be
very informative. Using regulatable promoters, such as the
galactose-inducible GAL1 promoter, to express activated
Bax in yeast generates conditionally lethal strains that have
been commonly used as a tool to carry out suicide survival
type screens. Such Bax suppressor screens were carried out
using cDNA libraries from a number of different mammalian
cell types and plant species (Table 1). Most groups have
identified multiple clones in each screen. For example, Seo
et al.51 have identified 24 different Bax suppressors from
their screen of a human glioblastoma cDNA library. The
functional diversity of different clones was surprising and
included sequences involved in signal transduction, redox
state, ubiquitination and DNA repair. We found a similar
diversity of function in the Bax suppressors identified in our
screens of mammalian cDNA libraries.52 The functions of
many of the identified clones, such as those involved in the
metabolism of free radicals, clearly implicate them as anti-
apoptotic sequences.53 In contrast, other clones, such as the
small GTPase Ran, require more elaborate scenarios to
explain the mechanism by which they inhibit Bax-mediated
cell death.54 However, there was no known function for
TMEM85 before being identified as an anti-apoptotic
protein.55 Thus the number and the diversity of clones
identified as Bax suppressors further serve to highlight the
complexity of the apoptotic responses to Bax in yeast, and
the usefulness of Bax-expressing yeast as a tool to identify
and characterize new anti-apoptotic sequences (Table 1).
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Many of these Bax suppressors, including Ran, ADP
ribosylation factor 4, Cyt c oxidase and HMGB1 have
already been shown to suppress cell death when
overexpressed in mammalian cells.51,54,56–57 In addition to
screens for suppressors, other researchers have used yeast
strains that conditionally express Bax to screen for mutants
that are resistant to Bax.33–34,58 Such a strategy has served
to identify yeast genes, including the gene encoding the
mitochondrial F0F1-ATPase proton pump, protein products
of which are required for the lethal effects of Bax.58 Many
Bax-resistant mutants identified were defective in their ability
to target Bax to the mitochondria.34,59 Using such a Bax-
resistant strain, a reverse genetic screen was used to identify
the C-terminal coding sequence of the yeast OYE2 gene
encoding the flavin mononucleotide (FMN) oxidoreductase
as a sequence that could restore Bax sensitivity.59 Further
analysis suggests that Oye2p interacts with the homologous
Oye3p and together they represent an important
heterodimeric complex that is involved in modulating
apoptotic and anti-apoptotic responses. Thus, as also
mentioned above, such genetic strategies also lead to
further clues regarding the mechanisms of Bax-mediated
cell death.
Analysis of Heterologous Expression of Caspases in
Yeast
Caspases are a family of specific aspartate cysteine
proteases that after activation cleave a wide range of
substrates, including other caspases, behaving as crucial
mediators of apoptosis. The family of caspases encompasses
several members that can be divided, according to their
structure and function, into initiators and effectors. Initiator
caspases are responsible for eliciting the apoptotic pathways
making a bridge between the adapter proteins and the effector
caspases, the executioners of the apoptotic program.60 The
attractiveness of yeast as a eukaryotic model cell for
molecular genetic analyses of apoptosis was also reflected
in its use for the study of expressed human caspases based
on the analysis of a ‘synthetic phenotype’. Expression of
caspase-3 in the yeastsP. pastoris60 andS. pombe61 resulted
in its auto-activation, after reaching a very high concentration,
and in the inhibition of yeast cell growth61 and S. pombe cell
death associated with DNA degradation.62 In contrast, the
expression of human caspase-3 in the yeast S. cerevisiae did
not result in its auto-activation and did not impair cell growth or
survival, suggesting a lack of zymogen processing and/or
caspase activity.63–64 To circumvent the observed lack of
caspase-3 auto-activation, the large and the small subunits of
caspase-3 were co-expressed allowing the intracellular
assembly of active protease,63 which resulted in the complete
loss of proliferative capacity of cells that nevertheless still
retained the ability to efficiently exclude the vital dye trypan
blue64 (Figure 2).
The use of yeast-based systems to understand caspases
regulation was further supported by the ability to model, in
yeast cells, human caspases activity through natural
adapters. In effect, the cytotoxicity of caspase-3 can be
abolished not only when mutant forms of the catalytic domain
of caspase-3 are expressed but also when genes encoding
specific inhibitors, such as the baculovirus protein
p35 or inhibitor of apoptosis proteins (IAPs), are co-
expressed.62,64–65 The co-expression of different human IAPs
is able to suppress caspase-3 cytotoxic effects in yeast with
Table 1 Clones capable of preventing Bax-mediated cell death in yeast
Clone Species/Cell type Reference
Mammalian
ADP-ribosylation factor 4 (ARF4) Human glioblastoma Woo et al.51
Ras-related nuclear protein (Ran) Human glioblastoma Woo et al.54
Transmembrane domain protein 85 (TMEM85) Human cardiac Ring et al.55
Cytochrome c oxidase subunit VIa polypeptide 1 (COX6A1) Human glioblastoma Eun et al.56
Transforming factor B stimulatory clone 22 (TSC22) Human cardiac Khoury et al.79
Peroxiredoxin (PrxI) Human and yeast (TSA1) Iraqui et al.80
Vesicular sorting protein 24-b (VPS24b) Human cardiac Khoury et al.81
Prion protein Mouse and human Li and Harris82
Sphingomyelin synthase 1 (SMS1a) Mouse T cell Yang et al.52
High-mobility group box-1 protein (HMGB1)a Mouse fibroblast Brezniceanu et al.57
Bifunctional apoptosis regulator (BAR) Human hepatocarcinoma Zhang et al.83
Bax antagonist selected in S. cerevisiae (BASS) Human cerebellum Greenhalf et al.84
Bax inhibitor (BI-1) Human hepatocarcinoma Xu and Reed85
Plants
Long-chain base 2 of serine palmitoyl transferase (BcLCB2) Brassica campestris Gan et al.86
(Chinese cabbage)
Glyceraldehyde-3-phosphate dehydrogenase Arabidopsis thaliana Baek et al.87
Avirulence 1b (Avr1b) Phytophthora sojae Dou et al.88
(water mold)
QM protein (Ribosomal protein L10) Lycopersicon esculentum (tomato) Chen et al.89
Phospholipid hydroperoxide glutathione peroxidase (LePHGPx) L. esculentum (tomato) Chen et al.53
Ascorbate peroxidase (sAPX) Soybean Moon et al.90
Ethylene-responsive element binding protein (AtEBP) A. thaliana Pan et al.91
Vesicle-associated membrane protein (AtVAMP) A. thaliana Levine et al.27
Glutathione S-transferase L. esculentum (tomato) Kampranis et al.36
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differing magnitudes for different members, with XIAP as the
most effective one and survivin being less efficient, which was
also confirmed, in parallel, in mammalian cells.64 Consis-
tently, another set of experiments using yeast-based systems
showed that the mammalian IAP homologues, MIHB and
MIHC, were much less effective than MIHA or p35 in
protecting against the toxicity of caspases.65 The inhibition
of caspase activity promoted by mammalian IAPs is also
reverted in yeast when IAP antagonist proteins, such as
DIABLO/Smac, HID and GRIM are co-expressed.65
As mentioned above human caspase activation in yeast
requires either their auto-activation by high expression levels
or natural activators such as other caspases or Apaf-1. In
effect, co-expression of procaspase-9 and procaspase-3, two
initiator caspases, in yeast was not toxic; however, when
active Apaf-1 is also expressed, it causes death of yeast cells,
suggesting that Apaf-1 activates procaspase-9, which in turn
activates procaspase-3, demonstrating that is also possible to
reconstitute the Apaf-1-activated pathway in yeast.65 An
elegant study by Kang et al.63 simultaneously addressed the
regulation of multiple human caspases activation in the yeast
S. cerevisiae. The authors expressed human caspase-8b,
-10, -3 and -6 to investigate the autocatalytic and sequential
proteolytic processing of these zymogens. Regulated expres-
sion of caspase-3 or -10 alone in yeast had no detectable
effect on cell viability, suggesting, as previously demonstrated
for caspase-3,61–64 a lack of zymogen processing. In contrast,
the expression of caspase-8b was extremely toxic and its
auto-activation was always accompanied by the appearance
of a small N-terminal fragment that, although insufficient to
catalyse the maturation of procaspase-8b, might be the result
of a yeast-encoded proteolytic activity.63 This hypothesis was
discarded on the basis of the observation that caspase-8b
cytotoxicity is abrogated when a catalytically inactive mutant
form is expressed.63
Only recently have the effects of heterologously expressing
caspases been analysed with regards to their potential
relationship to the yeast endogenous apoptotic regulators,
such as Yca1p and apoptosis-inducing factor (Aifp). The
expression of active mammalian, insect and nematode
caspases was shown to cause damage to yeast organelles
and lead to a reduction in clonogenic survival, in a manner
independent of Yca1p and Aif1p.66 Particularly, it was found
that expression of active human caspase-3 and -8 induced a
disruption of cellular membranes leading to damage of the
plasma membrane, loss of nuclei integrity and mitochondrial
structure but without evidence of DNA damage, as revealed
by a TUNEL-negative phenotype66 (Figure 2). Unlike what is
observed in mammalian cells, the authors found that active
heterologously expressed caspase-3 and -8 were unable to
cleave actin, this, in spite of the fact that yeast actin retains the
conserved cleavage sequence for caspase-3.66
Very recently, Lisa-Santamaria et al.67 further explored the
effect of the heterologous expression of the human initiator
caspases-8 and -10 in S. cerevisiae. It was shown that
their cytotoxic effects culminate in cell death with an
apoptotic phenotype characterized by production of ROS,
chromatin condensation and phosphatidylserine externaliza-
tion (Figure 2). In agreement with the results obtained in the
previous study on caspase-8,66 the authors found that
Figure 2 Study and functional analysis of heterologous expression of caspases in yeast
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caspase-8- and –caspase-10-induced lethality is independent
of Yca1p, Aif1p and of functional mitochondria, as revealed by
rho mutants.67 In addition, yeast cells expressing human
caspase-10 displayed an increased vacuolization suggesting
that an autophagic process might have been activated. Other
intracellular alterations, such as disorganization of the actin
cytoskeleton and aberrations within the endoplasmic reticu-
lum lumen, were also associated with caspase-10 expres-
sion.67 Altogether it seems clear that yeast could also provide
an excellent opportunity to study the regulation of human
caspases through the reconstitution of multiple caspases
pathways or the co-expression of natural caspase activators/
inhibitors. Yeast-based systems might not only give new
insights on the regulation of the different caspases activities
but might also reveal important roles of these proteases not
only in cell death but also in cell life.
Analysis of Tumour Suppressors in Yeast
Tumour suppressor genes encode gatekeeper proteins that
serve to regulate cell cycle and cell death and, therefore,
they are of critical importance in regulating cell fate.68 The
heterologous expression of many human genes encoding a
range of different tumour suppressors in yeast has served as a
useful system to characterize their structure and function.69
Yeast has also proven to be an excellent model system to
study tumour suppressor genes for which it does not have
orthologues, including p53, PTEN and BRAC1 (Table 2).69–72
Studies on the p53 tumour suppressor exemplify the
versatility of yeast to study different aspects of these
mammalian genes.69 For the most part, the early studies
focused on the use of yeast cells as naive or blank cells in
which to analyse p53. In accordance with its known function
as a transcription factor, early experiments were thus able
to show that the p53 could function as a sequence-specific
transcription factor in yeast.72 A variety of p53-responsive
reporter genes and detection systems have been and
continue to be developed and exploited to, among other
things, identify and characterize tumour-associated p53
mutants.69,72
Although the transcriptional activation function of p53 can
account for a number of its functions as a cellular gatekeeper,
it is clear that p53 also has numerous other cytoplasmic
roles.73 For example, p53 is thought to translocate to the
mitochondria in response to stresses, induce mitochondrial
membrane permeabilization and consequently induce
apoptosis by causing the release of pro-apoptotic factors.73
Similarly, the analysis of p53 in yeast suggested that p53 also
carries out other non-transcriptional functions.69 For example,
high levels of p53 expression inhibited cell cycle progression
in both fission and budding yeast.74–75 In S. cerevisiae, this
inhibition is enhanced by the heterologous expression of the
human cell cycle regulator protein kinase cdc2, whereas in
S. pompe the inhibitory effects of p53 are abrogated by the
overexpression of cell cycle regulator protein phosphatase
cdc25. Thus, p53 interacts with endogenous proteins to
regulate cell cycle progression in yeast. These early studies
seem to have uncovered a bona fide effect of p53 because a
recent study has reported that p53 regulates cell cycle
progression in mammalian cells by interacting with cdc25.76
Although it is quite clear that there is no direct orthologue of
p53 in the yeast genomes, these and various other studies77
suggest that a functional homologue to p53 is likely to exist in
yeast. Although alternative explanations exist, the ability of
these heterologous human apoptotic regulators to function in
yeast is largely taken as evidence for the underlying
similarities in the regulation of apoptosis in yeast and
mammalian cells.
Finally, the effects of high levels of p53 expression in yeast
have recently been revisited in light of the now well-accepted
paradigm of yeast apoptosis.47 It was found that p53
expressed from a strong galactose-inducible promoter results
in cell death that has many of the characteristics of apoptosis,
including phosphatidylserine exposure, DNA strand breaks
and the accumulation of ROS. Analysis of gene expression
profiles, by differential display, in yeast cells expressing p53
served to identify a decrease in the expression of the genes
encoding thioredoxin (TRX1/2). The thioredoxin genes are
stress-inducible genes that offer protection against ROS, and
like other antioxidant encoding genes they have roles as anti-
apoptotic regulators. Thus, p53 may induce apoptosis, in part,
by downregulating anti-apoptotic regulators. Observations in
mammalian cells also support this later idea, as previous
studies have made associations between alterations in Trx
expression in tumours in general, as well as in tumours with
mutant p53 genes.77 Earlier studies had noticed a link
between oxidative stress and p53 function in yeast.78 It was
reported that there was loss of the transcriptional factor
activity of p53 in yeast strains lacking the thioredoxin
reductase 1 (TRR1) gene. This observation was originally
Table 2 Mammalian tumour suppressor genes functionally expressed in yeast
Tumour suppressor Major effects of overexpression Yeast orthologue Reference
Protein 53 (p53) Induces apoptosis Noa Hadj Amor et al.77
B-cell CLL/lymphoma 2 (Bcl-2) Inhibits Bax-dependent and -independent apoptosis Noa Ligr et al.20
Phosphatase and tensin homologue
(PTEN)
Reconstitution of the mammalian PI3K/PTEN/Akt
signalling cascades
No Rodriguez-Escudero et al.92
Breast Cancer 1 (BRCA1) Inhibition of yeast growth No Humphrey et al.71
Retinoblastoma (RB) Enhances Hec1p chromosomal segregation No Zheng et al.93
Beclin-1 Induces autophagy; Inhibited by human Bcl-2 ATG6 Pattingre et al.37
Cyclin-dependent kinase (CDK4) Inhibition of yeast growth CDC28 Moorthamer et al.94
MutL homologue 1, colon cancer,
nonpolyposis type 2 (E. coli) (MLH1)
Increases mutation rate MLH1 Shimodaira et al.95
aAlthough there is no sequence orthologue to p53 or Bcl-2 in yeast, there is evidence to suggest that functional orthologues may exist
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ascribed to an increased oxidative stress-mediated loss in p53
structure in the yeast mutant. More likely, there is a direct link
between the apoptotic function of p53 and the oxidative state
of the cell. Thus, yeast may serve as an excellent model to
study the multitude and growing roles of p53 as an apoptotic
regulator.
Conclusions
More than one decade ago, scientists decided to exploit yeast
not only to understand how a cell lives but also to get new
insights about how a cell dies. Yeast were used as natural
knockout cells to reveal the structure and function of apoptotic
regulators, such as Bcl-2 members, caspases or tumour
suppressors without the interference of the complex network
of proteins involved in apoptosis. These approaches based on
the analysis of a ‘synthetic phenotype’ produced relevant
insights about the regulation and molecular interactions of
crucial apoptotic regulators. It was also possible to recon-
stitute in yeast cells several different pathways involving these
molecular apoptotic regulators highlighting that yeast will
continue to be a powerful system for the expression and
functional analysis of mammalian apoptotic regulators.
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